Fulfilling the Company’s goal of expanding the range of applications for its calibration technology SpheriCal®, the Company has now commercially released calibrants for Electrospray Ionization Mass Spectrometry (ESI-MS). The concept of this new technology was introduced to the market during the 71st ASMS Conference on Mass Spectrometry and Allied Topics (ASMS) this summer and prototypes were released for beta testing earlier this fall.

Currently, the Company has calibrants for MALDI-ToF MS commercially available, whereas the goal of the expansion of the SpheriCal® platform is to increase the target group and with that the market potential. It is estimated that the market size and number of instruments is many times higher for ESI than for MALDI-ToF. 

During 2023, Polymer Factory has engaged collaborators for evaluations within several new calibration areas, such as Ion Mobility Spectrometry (IMS) and high molecular weight MALDI, the latter which the Company released for beta testing in August. The results of the IMS development were presented by Polymer Factory’s Product Manager at ASMS in June 2023, which got a lot of attention and will be published in the scientific literature soon.

About SpheriCal®
Polymer Factory has developed SpheriCal® calibration technology, designed for MS instruments that measures the mass of molecules. SpheriCal® is used as a high-performance calibrant to ensure the instruments do not provide misleading data. SpheriCal® is an innovative technology designed to meet the calibration requirements of MALDI and ESI instruments. These MS techniques are widely applied to the analysis of biomolecules, e.g., DNA, proteins, peptides, and sugars, as well as large organic molecules including polymers, dendrimers, and other macromolecules, and for use in proteomics.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.